Edesa Biotech, Inc.EDSANASDAQ
Loading
Year-over-year free cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -18.23% |
| Q3 2025 | -0.83% |
| Q2 2025 | 24.95% |
| Q1 2025 | -53.77% |
| Q4 2024 | -56.89% |
| Q3 2024 | -12.91% |
| Q2 2024 | 48.88% |
| Q1 2024 | -19.13% |
| Q4 2023 | 4.19% |
| Q3 2023 | 18.68% |
| Q2 2023 | -14.83% |
| Q1 2023 | 12.22% |
| Q4 2022 | 68.18% |
| Q3 2022 | -85.86% |
| Q2 2022 | -624.70% |
| Q1 2022 | 86.99% |
| Q4 2021 | -807.36% |
| Q3 2021 | 88.67% |
| Q2 2021 | 56.52% |
| Q1 2021 | -138.49% |
| Q4 2020 | -79.59% |
| Q3 2020 | -21.28% |
| Q2 2020 | -18.14% |
| Q1 2020 | -48.21% |
| Q4 2019 | 40.72% |
| Q3 2019 | 40.39% |
| Q2 2019 | -73.68% |
| Q1 2019 | 2.11% |
| Q4 2018 | -32.42% |
| Q3 2018 | 21.65% |
| Q2 2018 | 18.76% |
| Q1 2018 | -32.25% |
| Q4 2017 | 3.30% |
| Q3 2017 | -20.17% |
| Q2 2017 | 23.04% |
| Q1 2017 | 9.03% |
| Q4 2016 | -11.58% |
| Q3 2016 | -18.31% |
| Q2 2016 | 5.44% |
| Q1 2016 | 13.96% |